Literature DB >> 20736370

Spontaneous tumorigenesis in mice overexpressing the p53-negative regulator Mdm4.

Shunbin Xiong1, Vinod Pant, Young-Ah Suh, Carolyn S Van Pelt, Yongxing Wang, Yasmine A Valentin-Vega, Sean M Post, Guillermina Lozano.   

Abstract

High levels of the critical p53 inhibitor Mdm4 is common in tumors that retain a wild-type p53 allele, suggesting that Mdm4 overexpression is an important mechanism for p53 inactivation during tumorigenesis. To test this hypothesis in vivo, we generated transgenic mice with widespread expression of Mdm4. Two independent lines of transgenic mice, Mdm4(Tg1) and Mdm4(Tg15), developed spontaneous tumors, the most prevalent of which were sarcomas. To determine whether overexpression of Mdm4 also cooperated with p53 heterozygosity to induce tumorigenesis, we generated Mdm4(Tg1) p53(+/-) mice. These mice had significantly accelerated tumorigenesis and a distinct tumor spectrum with more carcinomas and significantly fewer lymphomas than p53(+/-) or Mdm4(Tg1) mice. Importantly, the remaining wild-type p53 allele was retained in most Mdm4(Tg1) p53(+/-) tumors. Mdm4 is thus a bona fide oncogene in vivo and cooperates with p53 heterozygosity to drive tumorigenesis. These Mdm4 mice will be invaluable for in vivo drug studies of Mdm4 inhibitors. ©2010 AACR.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20736370      PMCID: PMC2940952          DOI: 10.1158/0008-5472.CAN-10-1457

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  40 in total

1.  ATM and Chk2-dependent phosphorylation of MDMX contribute to p53 activation after DNA damage.

Authors:  Lihong Chen; Daniele M Gilkes; Yu Pan; William S Lane; Jiandong Chen
Journal:  EMBO J       Date:  2005-09-15       Impact factor: 11.598

2.  MDMX overexpression prevents p53 activation by the MDM2 inhibitor Nutlin.

Authors:  Baoli Hu; Daniele M Gilkes; Bilal Farooqi; Said M Sebti; Jiandong Chen
Journal:  J Biol Chem       Date:  2006-08-11       Impact factor: 5.157

3.  14-3-3gamma binds to MDMX that is phosphorylated by UV-activated Chk1, resulting in p53 activation.

Authors:  Yetao Jin; Mu-Shui Dai; Steven Z Lu; Yingda Xu; Zhijun Luo; Yingming Zhao; Hua Lu
Journal:  EMBO J       Date:  2006-03-02       Impact factor: 11.598

4.  Synergistic roles of Mdm2 and Mdm4 for p53 inhibition in central nervous system development.

Authors:  Shunbin Xiong; Carolyn S Van Pelt; Ana C Elizondo-Fraire; Geng Liu; Guillermina Lozano
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-21       Impact factor: 11.205

5.  Phosphorylation of Hdmx mediates its Hdm2- and ATM-dependent degradation in response to DNA damage.

Authors:  Yaron Pereg; Dganit Shkedy; Petra de Graaf; Erik Meulmeester; Marina Edelson-Averbukh; Mogjiborahman Salek; Sharon Biton; Amina F A S Teunisse; Wolf D Lehmann; Aart G Jochemsen; Yosef Shiloh
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-23       Impact factor: 11.205

6.  DNA damage-induced phosphorylation of MdmX at serine 367 activates p53 by targeting MdmX for Mdm2-dependent degradation.

Authors:  Koji Okamoto; Kenji Kashima; Yaron Pereg; Michiko Ishida; Satomi Yamazaki; Ayumi Nota; Amina Teunisse; Domenico Migliorini; Issay Kitabayashi; Jean-Christophe Marine; Carol Prives; Yosef Shiloh; Aart G Jochemsen; Yoichi Taya
Journal:  Mol Cell Biol       Date:  2005-11       Impact factor: 4.272

7.  Inactivation of the p53 pathway in retinoblastoma.

Authors:  Nikia A Laurie; Stacy L Donovan; Chie-Schin Shih; Jiakun Zhang; Nicholas Mills; Christine Fuller; Amina Teunisse; Suzanne Lam; Yolande Ramos; Adithi Mohan; Dianna Johnson; Matthew Wilson; Carlos Rodriguez-Galindo; Micaela Quarto; Sarah Francoz; Susan M Mendrysa; R Kiplin Guy; Jean-Christophe Marine; Aart G Jochemsen; Michael A Dyer
Journal:  Nature       Date:  2006-11-02       Impact factor: 49.962

Review 8.  The role of p53 in tumour suppression: lessons from mouse models.

Authors:  L D Attardi; T Jacks
Journal:  Cell Mol Life Sci       Date:  1999-01       Impact factor: 9.261

Review 9.  Mdmx and Mdm2: brothers in arms?

Authors:  Jean-Christophe Marine; Aart G Jochemsen
Journal:  Cell Cycle       Date:  2004-07-02       Impact factor: 4.534

10.  Levels of HdmX expression dictate the sensitivity of normal and transformed cells to Nutlin-3.

Authors:  John T Patton; Lindsey D Mayo; Aatur D Singhi; Andrei V Gudkov; George R Stark; Mark W Jackson
Journal:  Cancer Res       Date:  2006-03-15       Impact factor: 12.701

View more
  47 in total

1.  The p53 inhibitor Mdm4 cooperates with multiple genetic lesions in tumourigenesis.

Authors:  Shunbin Xiong; Vinod Pant; Yun Zhang; Neeraj K Aryal; M James You; Donna Kusewitt; Guillermina Lozano
Journal:  J Pathol       Date:  2017-01-06       Impact factor: 7.996

Review 2.  Genome Stability Requires p53.

Authors:  Christine M Eischen
Journal:  Cold Spring Harb Perspect Med       Date:  2016-06-01       Impact factor: 6.915

Review 3.  Pharmacological activation of wild-type p53 in the therapy of leukemia.

Authors:  Kensuke Kojima; Jo Ishizawa; Michael Andreeff
Journal:  Exp Hematol       Date:  2016-06-18       Impact factor: 3.084

Review 4.  Attenuating the p53 Pathway in Human Cancers: Many Means to the Same End.

Authors:  Amanda R Wasylishen; Guillermina Lozano
Journal:  Cold Spring Harb Perspect Med       Date:  2016-08-01       Impact factor: 6.915

5.  Haploinsufficiency of del(5q) genes, Egr1 and Apc, cooperate with Tp53 loss to induce acute myeloid leukemia in mice.

Authors:  Angela Stoddart; Anthony A Fernald; Jianghong Wang; Elizabeth M Davis; Theodore Karrison; John Anastasi; Michelle M Le Beau
Journal:  Blood       Date:  2013-12-31       Impact factor: 22.113

Review 6.  Illuminating p53 function in cancer with genetically engineered mouse models.

Authors:  Patty B Garcia; Laura D Attardi
Journal:  Semin Cell Dev Biol       Date:  2014-01-03       Impact factor: 7.727

7.  Tissue-specific and age-dependent effects of global Mdm2 loss.

Authors:  Yun Zhang; Shunbin Xiong; Qin Li; Sophia Hu; Mehrnoosh Tashakori; Carolyn Van Pelt; Mingjian James You; Laura Pageon; Guillermina Lozano
Journal:  J Pathol       Date:  2014-06-09       Impact factor: 7.996

Review 8.  The Mdm network and its regulation of p53 activities: a rheostat of cancer risk.

Authors:  Christine M Eischen; Guillermina Lozano
Journal:  Hum Mutat       Date:  2014-03-06       Impact factor: 4.878

9.  Using Mouse Models to Explore MDM-p53 Signaling in Development, Cell Growth, and Tumorigenesis.

Authors:  Hugh S Gannon; Stephen N Jones
Journal:  Genes Cancer       Date:  2012-03

10.  Protecting the genome from mdm2 and mdmx.

Authors:  Alexia N Melo; Christine M Eischen
Journal:  Genes Cancer       Date:  2012-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.